A61K 38/1833
Hepatocyte growth factor
Official title: {Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II}
A61K38/1833 (Hepatocyte growth factor) appears on 218 US grants and 383 published applications in this corpus.
Search patents in A61K- Granted patents
- 218
- Published applications
- 383
- Assignees
- 214
- Inventors
- 649
- Latest grant
- 17 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 3 | 0 |
| 1997 | 5 | 0 |
| 1998 | 5 | 0 |
| 1999 | 8 | 0 |
| 2000 | 9 | 0 |
| 2001 | 2 | 3 |
| 2002 | 4 | 7 |
| 2003 | 0 | 12 |
| 2004 | 3 | 11 |
| 2005 | 4 | 14 |
| 2006 | 5 | 24 |
| 2007 | 5 | 12 |
| 2008 | 2 | 21 |
| 2009 | 11 | 17 |
| 2010 | 7 | 12 |
| 2011 | 6 | 9 |
| 2012 | 7 | 11 |
| 2013 | 7 | 19 |
| 2014 | 12 | 14 |
| 2015 | 5 | 15 |
| 2016 | 11 | 17 |
| 2017 | 8 | 23 |
| 2018 | 10 | 12 |
| 2019 | 19 | 21 |
| 2020 | 15 | 15 |
| 2021 | 10 | 15 |
| 2022 | 8 | 14 |
| 2023 | 11 | 14 |
| 2024 | 7 | 20 |
| 2025 | 8 | 23 |
| 2026 | 1 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Allogeneic human plasma and platelet derived products and uses thereof17 Mar 2026US 12,576,109 B2Consano Bio, Inc.
- Micronized compositions for wound healing prepared from intact human amnion-chorion tissue having an intact intermediate spongy layer positioned there between25 Nov 2025US 12,478,647 B2Biostem Technologies, Inc.
- Bioactive granular hydrogel scaffolds and use thereof29 Jul 2025US 12,370,138 B2The Penn State Research Foundation
- Sterile human placental allografts having a plurality of slits, openings, and/or fenestrations formed thereon29 Jul 2025US 12,370,223 B2Biostem Technologies, Inc.
- Composition for increasing the expression of a growth factor gene, comprising coreshell structured microparticles as active ingredient22 Apr 2025US 12,280,155 B2G&P Bioscience Co., Ltd.
- Micronized compositions for wound healing prepared from human umbilical cord tissue and intact amnion-chorion tissue having an intact intermediate spongy layer positioned there between1 Oct 2026US 2026/0294982 A1Biostem Technologies, Inc.
- Recombinant protein compositions useful for wound healing10 Sep 2026US 2026/0263559 A1Wake Forest University Health Sciences
- Enhancer of physiological activity of hepatocyte growth factor20 Aug 2026US 2026/0240836 A1Kyowa Hakko Bio Co., Ltd.
- Hair growth and anti-hair greying composition13 Aug 2026US 2026/0232751 A1
- Allogeneic human plasma and platelet derived products and uses thereof2 Jul 2026US 2026/0183336 A1Consano Bio, Inc.
Most cited
By later US patents
- Supplemented and unsupplemented tissue sealants, methods of their production and use292US 6,054,122 AAmerican National Red Cross · 2000
- Treatment of retinitis pigmentosa with human umbilical cord cells175US 7,413,734 B2Ethicon, Inc. · 2008
- Postpartum cells isolated from umbilical cord tissue, and methods of making and using the same84US 7,510,873 B2Ethicon, Inc. · 2009
- Soft tissue repair and regeneration using postpartum-derived cells76US 7,560,276 B2Ethicon, Inc. · 2009
- Regeneration and repair of neural tissue using postpartum-derived cells58US 7,524,489 B2Ethicon, Inc. · 2009